SCHEMBL9998362

SCHEMBL9998362

CC(=O)OC(OC(C)=O)C(=Cc1cccc(Cl)c1)C(C)C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.42
CYP2C9 P11712 2/20 0.42
FBP1 P09467 1/20 0.41
KMT2A Q03164 4/20 0.41
MEN1 O00255 3/20 0.41
HPGD P15428 3/20 0.40
AKR1C3 P42330 1/20 0.40
ALOX15 P16050 1/20 0.40
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
POLB P06746 1/20 0.39
PKM P14618 1/20 0.39
PTGS2 P35354 1/20 0.39
KCNA3 P22001 1/20 0.39
CYP2C19 P33261 2/20 0.38
MAOB P27338 3/20 0.38
NPC1 O15118 1/20 0.36
LMNA P02545 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9997605 0.84 LMNA (0.44) FBP1KMT2AMEN1HPGDKDM4E
SCHEMBL9998493 0.84 CYP1A2 (0.45) CYP1A2CYP2C9FBP1KMT2AMEN1
SCHEMBL9998495 0.84 CYP1A2 (0.45) CYP1A2CYP2C9FBP1KMT2AMEN1
SCHEMBL9997490 0.83 HSD17B3 (0.42) KMT2AMEN1HPGDAKR1C3ALDH1A1
SCHEMBL9998522 0.83 PTGS1 (0.43) CYP1A2FBP1HPGDAKR1C3PKM
SCHEMBL9998047 0.83 ALDH1A1 (0.36) HPGDALOX15KDM4EALDH1A1LMNA
SCHEMBL9998385 0.83 KMT2A (0.43) CYP1A2CYP2C9FBP1KMT2AMEN1
SCHEMBL9998384 0.83 KMT2A (0.43) CYP1A2CYP2C9FBP1KMT2AMEN1
SCHEMBL9998589 0.82 CYP2C9 (0.43) CYP1A2CYP2C9FBP1KMT2AMEN1
SCHEMBL9997311 0.82 AKR1C3 (0.46) FBP1KMT2AMEN1AKR1C3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8558012-B2 2-fluoro-1,3-benzodithiol 1,1,3,3-tetraoxide derivative, production method thereof, and production method of monofluoromethyl group-containing compound using the same NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2013-10-15 US disclosed
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2011-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME CBR1, CYP1B1, CYP2F1 CYP1A2 19/4885CYP2C9 28/4885FBP1 181/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.